About Us
Enbana Labs is a Medtech and Biotech venture headquartered in India, focused on translating proven diagnostic concepts into robust, field-ready products.
Our core mandate is to build an Indian manufacturing base for high-impact health technologies that are currently imported or not available at scale, starting with tools that support tuberculosis treatment adherence.
Enbana Labs manufactures IsoScreen® as a Research Use Only (RUO) urine test that detects isoniazid (INH) intake, giving researchers and programme teams an objective view of tuberculosis treatment adherence in real-world settings.
Our current focus: IsoScreen™ RUO
IsoScreen® RUO is a rapid, urine-based biochemical test that detects metabolites of isoniazid (INH), a first-line TB drug.
It provides a simple colour change read-out that indicates recent ingestion of TB medication, supporting adherence research, programme evaluation, and operational studies.
Manufactured in India and supplied as Research Use Only (RUO), IsoScreen® is used with partners to integrate objective adherence testing into TB research and programme evaluations.
Who we work with
Researchers & trial teams
Integrating IsoScreen™ RUO as an adherence endpoint in clinical and implementation studies.
TB programmes
Using targeted sub-studies and evaluations to understand adherence gaps and optimise counselling.
Global health projects & NGOs
Generating real-world evidence to support interventions and funding decisions.